News Industry News U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure June 26, 2019
News Industry News Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure June 13, 2016
News Industry News BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators May 04, 2016
News Industry News Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments January 03, 2016
News Industry News Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure August 31, 2015
News Industry News Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority June 22, 2015
News Industry News First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit June 09, 2015